Modeling disease progression with longitudinal markers

Lurdes Y.T. Inoue, Ruth Etzioni, Christopher Morrell, Peter Müller

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


In this article we propose a Bayesian natural history model for disease progression based on the joint modeling of longitudinal biomarker levels, age at clinical detection of disease, and disease status at diagnosis. We establish a link between the longitudinal responses and the natural history of the disease by using an underlying latent disease process that describes the onset of the disease and models the transition to an advanced stage of the disease as dependent on the biomarker levels. We apply our model to data from the Baltimore Longitudinal Study of Aging on prostate-specific antigen to investigate the natural history of prostate cancer.

Original languageEnglish (US)
Pages (from-to)259-270
Number of pages12
JournalJournal of the American Statistical Association
Issue number481
StatePublished - Mar 2008
Externally publishedYes


  • Disease progression
  • Latent variables
  • Longitudinal response
  • Markov chain Monte Carlo methods
  • Natural history model
  • Prostate-specific antigen

ASJC Scopus subject areas

  • Statistics and Probability
  • Statistics, Probability and Uncertainty


Dive into the research topics of 'Modeling disease progression with longitudinal markers'. Together they form a unique fingerprint.

Cite this